These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
64. Emerging role of NF-κB signaling in the induction of senescence-associated secretory phenotype (SASP). Salminen A; Kauppinen A; Kaarniranta K Cell Signal; 2012 Apr; 24(4):835-45. PubMed ID: 22182507 [TBL] [Abstract][Full Text] [Related]
65. Hematopoietic stem cell-derived adipocytes and fibroblasts in the tumor microenvironment. Xiong Y; McDonald LT; Russell DL; Kelly RR; Wilson KR; Mehrotra M; Soloff AC; LaRue AC World J Stem Cells; 2015 Mar; 7(2):253-65. PubMed ID: 25815113 [TBL] [Abstract][Full Text] [Related]
66. MLL1 is essential for the senescence-associated secretory phenotype. Capell BC; Drake AM; Zhu J; Shah PP; Dou Z; Dorsey J; Simola DF; Donahue G; Sammons M; Rai TS; Natale C; Ridky TW; Adams PD; Berger SL Genes Dev; 2016 Feb; 30(3):321-36. PubMed ID: 26833731 [TBL] [Abstract][Full Text] [Related]
68. Cancer-associated adipocytes: key players in breast cancer progression. Wu Q; Li B; Li Z; Li J; Sun S; Sun S J Hematol Oncol; 2019 Sep; 12(1):95. PubMed ID: 31500658 [TBL] [Abstract][Full Text] [Related]
69. Engulfment and cannibalism drive persistence of chemotherapy-treated tumor cells: can they be targeted? Tonnessen-Murray CA; Jackson JG Mol Cell Oncol; 2020; 7(1):1688601. PubMed ID: 31993500 [TBL] [Abstract][Full Text] [Related]
70. Enhancing chemotherapy efficacy by reprogramming the senescence-associated secretory phenotype of prostate tumors: A way to reactivate the antitumor immunity. Toso A; Di Mitri D; Alimonti A Oncoimmunology; 2015 Mar; 4(3):e994380. PubMed ID: 25949917 [No Abstract] [Full Text] [Related]
71. Unraveling the nexus between cellular senescence and malignant transformation: a paradigm shift in cancer research. Song X; Liu X; Guo Q; Xu H; Cao L Cancer Biol Med; 2024 Jun; ():. PubMed ID: 38940671 [No Abstract] [Full Text] [Related]
73. Centrosome dysfunction: a link between senescence and tumor immunity. Wu Q; Li B; Liu L; Sun S; Sun S Signal Transduct Target Ther; 2020 Jun; 5(1):107. PubMed ID: 32606370 [TBL] [Abstract][Full Text] [Related]
74. Cancer-associated adipocytes as immunomodulators in cancer. Wu Q; Li B; Li J; Sun S; Yuan J; Sun S Biomark Res; 2021 Jan; 9(1):2. PubMed ID: 33413697 [TBL] [Abstract][Full Text] [Related]
75. The Dynamic Process and Its Dual Effects on Tumors of Therapy-Induced Senescence. Liao C; Xiao Y; Liu L Cancer Manag Res; 2020; 12():13553-13566. PubMed ID: 33408525 [TBL] [Abstract][Full Text] [Related]
76. Engineered 3D ex vivo models to recapitulate the complex stromal and immune interactions within the tumor microenvironment. Ravi K; Manoharan TJM; Wang KC; Pockaj B; Nikkhah M Biomaterials; 2024 Mar; 305():122428. PubMed ID: 38147743 [TBL] [Abstract][Full Text] [Related]
77. Adipocyte Microenvironment in Ovarian Cancer: A Critical Contributor? Duarte Mendes A; Freitas AR; Vicente R; Vitorino M; Vaz Batista M; Silva M; Braga S Int J Mol Sci; 2023 Nov; 24(23):. PubMed ID: 38068912 [TBL] [Abstract][Full Text] [Related]
78. Bone marrow adipocytes induce cancer-associated fibroblasts and immune evasion, enhancing invasion and drug resistance. Sato S; Hiruma T; Koizumi M; Yoshihara M; Nakamura Y; Tadokoro H; Motomatsu S; Yamanaka T; Washimi K; Okubo Y; Yoshioka E; Kasajima R; Yamashita T; Kishida T; Yokose T; Miyagi Y Cancer Sci; 2023 Jun; 114(6):2674-2688. PubMed ID: 36916999 [TBL] [Abstract][Full Text] [Related]
79. Tumor Microenvironment-A Short Review of Cellular and Interaction Diversity. Bożyk A; Wojas-Krawczyk K; Krawczyk P; Milanowski J Biology (Basel); 2022 Jun; 11(6):. PubMed ID: 35741450 [TBL] [Abstract][Full Text] [Related]